StonvexLoading…
StonvexStonvexStonvexCore line items from OPFI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $159.64M | $87.30M | $381.18M | $295.61M | $191.06M |
Operating Income | Not available | $35.36M | $166.68M | $135.75M | $87.30M |
Net Income | Not available | $28.40M | $26.33M | $9.48M | $-32.15M |
EPS (Diluted) | $0.46 | $0.56 | $0.99 | $0.36 | $-1.28 |
Total Assets | Not available | $719.99M | $754.09M | $720.62M | $673.38M |
Total Liabilities | Not available | $377.00M | $445.21M | $443.36M | $455.67M |
Cash & Equivalents | Not available | $63.87M | $49.45M | $45.45M | $45.23M |
Free Cash Flow OCF − CapEx | Not available | $85.63M | $382.19M | $270.26M | $170.33M |
Shares Outstanding | Not available | 86.20M | 26.51M | 26.17M | 25.16M |